Advertisement

Topics

Search Results for "Micrus Endovascular Merger"

16:42 EDT 28th September 2016 | BioPortfolio

Matching Channels

Jobs in Endovascular

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...

Matching News

Endovascular therapy trumps tPA for distal stroke clot treatment

When it comes to hard-to-reach blood clots, endovascular therapy is an effective—and superior—method to medical management, according to a recent study by the University of Texas Health Science Ce...

MR CLEAN at 2 Years: Sustained Endovascular Benefit in Stroke

The first long-term results from the new crop of endovascular trials in stroke show consistent benefit on functional outcomes and suggest a reduction in mortality. Medscape Medical News

Pfizer, Allergan Reportedly End Merger Deal

Pfizer is planning to terminate its $152 billion merger with Allergan, after the U.S. Treasury Department proposed new tax regulations that would reduce the proposed merger’s advantages, the New Yor...

Trial begins for Intact Vascular's endovascular system

A 200-patient, multisite clinical trial has been launched by Wayne, Pa.-based Intact Vascular to assess its Tack endovascular -More- 

Merger mania

Ebb & Flow Merger mania The unraveling of the merger between Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) has some generalist investors betting bid prices will get more competitive as the two gi...

Baxalta Announces Shareholder Approval For Merger Deal With Shire

SAINT HELIER (dpa-AFX) - Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transact...

European Commission clears merger between IMS and Quintiles

The European Commission has approved under the EU Merger Regulation a proposed merger between IMS Health…

Article Selection and Possible Risk of Bias—Reply

In Reply Dr Elgendy and colleagues suggest that the SYNTHESIS trial should have been excluded from our meta-analysis because the endovascular therapy group did not receive intravenous tPA. At the time...

Matching PubMed Articles

Thinking Out of the Box to Increase Technical Success in Fenestrated and Branched Endovascular Aneurysm Repair.

A 15-Year Single-Center Experience of Endovascular Repair for Elective and Ruptured Abdominal Aortic Aneurysms.

To evaluate the differences in technical outcomes and secondary interventions between elective endovascular aneurysm repair (el-EVAR) procedures and those for ruptured aneurysms (r-EVAR).

Endovascular Treatment of Degenerative Aneurysms Involving Only the Descending Thoracic Aorta: Systematic Review and Meta-analysis.

To determine the efficacy of thoracic endovascular aortic repair (TEVAR) for degenerative aneurysm involving only the descending thoracic aorta (DTAA).

Endovascular Closure of Chronic Dissection Entries in the Aortic Arch Using the Amplatzer Vascular Plug II as a Sealing Button.

To present a new endovascular technique to avoid open surgical arch reconstruction in selected patients with aneurysmal dilatation due to small chronic dissection entries in the aortic arch.

Midterm Outcomes of the Nellix Endovascular Aneurysm Sealing System: A Dual-Center Experience.

To report midterm outcomes of the Nellix Endovascular Aneurysm Sealing (EVAS) System in the treatment of abdominal aortic aneurysm (AAA).

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement